Cargando…

Immunosuppressants/Antifungals: COVID-19 associated mucormycosis, COVID-19 associated pulmonary aspergillosis and lack of efficacy: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897069/ http://dx.doi.org/10.1007/s40278-022-11040-6

Ejemplares similares

Pulmonary aspergillosis and mucormycosis in a patient with COVID-19
por: Johnson, Andre K., et al.
Publicado: (2021)

COVID-19 associated with concomitant mucormycosis and aspergillosis
por: Lai, Chih-Cheng, et al.
Publicado: (2022)

COVID-19 associated mold infections: Review of COVID-19 associated pulmonary aspergillosis and mucormycosis
por: Huang, Shiang-Fen, et al.
Publicado: (2023)

Multiple drugs: COVID-19-associated invasive pulmonary aspergillosis, Off-label use and lack of efficacy: case report
Publicado: (2021)

Mucormycosis and aspergillosis: The deadly duo in COVID-19—a case report
por: Mohanty, Bijaya, et al.
Publicado: (2022)

Immunosuppressants and antiviral: COVID-19 and lack of efficacy: case report
Publicado: (2022)

Dexamethasone: Pulmonary aspergillosis and mucormycosis: case report
Publicado: (2021)

Diagnosis and Antifungal Prophylaxis for COVID-19 Associated Pulmonary Aspergillosis
por: Hawes, Armani M., et al.
Publicado: (2022)

A case report of COVID-19 associated pulmonary mucormycosis
por: Khan, Nariman, et al.
Publicado: (2021)

Renal aspergillosis after COVID‐19‐associated pulmonary aspergillosis: A case report
por: Ghasemian, Roya, et al.
Publicado: (2023)

CONCOMITANT PULMONARY MUCORMYCOSIS AND PULMONARY ASPERGILLOSIS IN A YOUNG PATIENT WITH COVID-19
por: FELDMAN, ERICA, et al.
Publicado: (2021)

COVID-19 associated pulmonary aspergillosis (CAPA): An Australian case report
por: Sharma, Avinash, et al.
Publicado: (2020)

Antifungals/prednisone: COVID-19, disseminated infection by Scopulariopsis and lack of efficacy: case report
Publicado: (2021)

COVID-19 associated with pulmonary mucormycosis; a case series
por: Ahmed, Okba F., et al.
Publicado: (2022)

Dexamethasone: Pulmonary mucormycosis, pulmonary aspergillosis and off-label use: case report
Publicado: (2021)

The rise in cases of mucormycosis, candidiasis and aspergillosis amidst COVID19
por: Ghosh, Asmita, et al.
Publicado: (2021)

Two cases of COVID‐19‐associated pulmonary aspergillosis (CAPA)
por: Lim, Jin Lee, et al.
Publicado: (2022)

COVID-19-associated Pulmonary Aspergillosis: A Case Series
por: Sharma, Khushboo, et al.
Publicado: (2022)

Unusual manifestation of COVID‐19‐associated pulmonary aspergillosis: A case report
por: Albaji, Maryam, et al.
Publicado: (2022)

Case Report: Immune Checkpoint Blockade Plus Interferon-Γ Add-On Antifungal Therapy in the Treatment of Refractory Covid-Associated Pulmonary Aspergillosis and Cerebral Mucormycosis
por: Serris, Alexandra, et al.
Publicado: (2022)

COVID-19 Associated Pulmonary Aspergillosis: Diagnostic Performance, Fungal Epidemiology and Antifungal Susceptibility
por: Lackner, Nina, et al.
Publicado: (2022)

COVID-19-Associated Pulmonary Mucormycosis
por: Krishna, Vidya, et al.
Publicado: (2022)

COVID-19-associated pulmonary aspergillosis in a Japanese man: A case report
por: Imoto, Waki, et al.
Publicado: (2021)

Multiple drugs: COVID-19-associated pulmonary aspergillosis infection: 8 case reports
Publicado: (2021)

COVID‐19 associated pulmonary aspergillosis
por: Koehler, Philipp, et al.
Publicado: (2020)

COVID-19–associated Pulmonary Aspergillosis
por: van Arkel, Andreas L. E., et al.
Publicado: (2020)

COVID-19 associated pulmonary aspergillosis
por: Álvarez Fernández, M., et al.
Publicado: (2023)

A fatal case of COVID-19-associated invasive pulmonary aspergillosis
por: Iwanaga, Yuto, et al.
Publicado: (2021)

Multiple drugs: Mucormycosis and lack of efficacy: case report
Publicado: (2022)

COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review
por: Benhadid-Brahmi, Yasmine, et al.
Publicado: (2022)

Immunosuppressants/voriconazole: COVID-19 infection, invasive systemic aspergillosis and visual disturbance: case report
Publicado: (2021)

COVID-19-associated disseminated mucormycosis: An autopsy case report
por: Kyuno, Daisuke, et al.
Publicado: (2022)

Voriconazole: Lack of efficacy during treatment of invasive pulmonary aspergillosis: 2 case reports
Publicado: (2021)

A CASE OF COVID-19-ASSOCIATED PULMONARY ASPERGILLOSIS
por: LIN, KAIQING, et al.
Publicado: (2022)

Immunosuppressants/azithromycin: Prolonged COVID-19 infection, off label use and lack of efficacy: case report
Publicado: (2021)

Antineoplastics/immunosuppressants: Lack of efficacy, graft versus host disease and COVID-19 pneumonia: case report
Publicado: (2021)

Tumor shape pulmonary mucormycosis associated with sinonasal aspergillosis in a diabetic patient
por: Point, Sophie, et al.
Publicado: (2017)

Comparative risk assessment of COVID‐19 associated mucormycosis and aspergillosis: A systematic review
por: Baral, Prodip Kumar, et al.
Publicado: (2022)

Critical COVID-19-associated pulmonary mucormycosis: The underreported life-threatening spectrum of the mucormycosis epidemic
por: Mehta, Ravindra M, et al.
Publicado: (2022)

Azole-Resistant COVID-19-Associated Pulmonary Aspergillosis in an Immunocompetent Host: A Case Report
por: Meijer, Eelco F. J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_llpgkil99dpmsrkul9678dubgm